ReviewPharmaceuticals (Basel, Switzerland)2025

Oritavancin a Therapeutic Option for Periprosthetic Joint Infections in Selected Cases: A Comprehensive Review.

Rares-Mircea Birlutiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.